[Comment] Antiangiogenic treatment in metastatic urothelial cancer
00:15 EDT 20 Jul 2012 | The Lancet
Advances in the treatment of metastatic urothelial cancer have been elusive for several decades. However, more than 30 years ago, Chodak and colleagues showed that the urine of patients with urothelial cancer contains proangiogenic substances. Other..
Original Article: [Comment] Antiangiogenic treatment in metastatic urothelial cancer
More From BioPortfolio on "[Comment] Antiangiogenic treatment in metastatic urothelial cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
